Pinnacle West Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.41M Sell
13,955
-705
-5% -$164K 2.32% 10
2025
Q4
$3.03M Sell
14,660
-300
-2% -$59.3K 1.97% 13
2025
Q3
$2.77M Buy
14,960
+10
+0.1% +$1.71K 1.8% 15
2025
Q2
$2.28M Sell
14,950
-255
-2% -$39.2K 1.58% 17
2025
Q1
$2.52M Buy
15,205
+60
+0.4% +$9.39K 1.82% 15
2024
Q4
$2.19M Hold
15,145
1.57% 19
2024
Q3
$2.45M Buy
15,145
+25
+0.2% +$3.98K 1.76% 13
2024
Q2
$2.21M Buy
15,120
+100
+0.7% +$14.9K 1.72% 15
2024
Q1
$2.38M Sell
15,020
-200
-1% -$31.8K 1.89% 11
2023
Q4
$2.39M Buy
15,220
+600
+4% +$92K 2.05% 9
2023
Q3
$2.28M Buy
14,620
+775
+6% +$128K 2.23% 9
2023
Q2
$2.29M Sell
13,845
-100
-0.7% -$16.1K 2.23% 5
2023
Q1
$2.16M Buy
+13,945
New +$2.25M 2.26% 5

Other funds holding JNJ

Pinnacle West Asset Management's JNJ Position: Q1 2026 in Review

Pinnacle West Asset Management reduced its Johnson & Johnson (JNJ) stake by 4.8% in Q1 2026, selling an estimated $164K and leaving 13,955 shares worth $3.41M. The position accounts for 2.32% of the portfolio, ranked #10.

Pinnacle West Asset Management first reported a position in JNJ in Q1 2023 and has held it in 13 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Pinnacle West Asset Management held 13,955 shares of Johnson & Johnson worth $3.41M as of Q1 2026.
  • Pinnacle West Asset Management sold 705 Johnson & Johnson shares in Q1 2026, an estimated $164K.
  • Johnson & Johnson made up 2.32% of Pinnacle West Asset Management's portfolio in Q1 2026, its #10 holding.
  • Pinnacle West Asset Management first reported a position in Johnson & Johnson in Q1 2023 and has held it in 13 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Pinnacle West Asset Management's 13F filing for Q1 2026, filed 15 May 2026.